Work

Phase I Trial of ‘Re-Priming’ Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Year: 2023

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2023.06.334

Authors: K.A. Kumar, R. Ravella, P. Ramakrishnan Geethakumari, F. Awan, T.A. Aguilera, X. Li, O.K. Öz, A. Kandathil, W. Chen, F. Fuda, C. Ahn, P. Iyengar, N.B. Desai, R.D. Timmerman

Institutions: The University of Texas Southwestern Medical Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Boston Scientific Corporation

OpenAlex ID: W4387207565

FWCI: 0.122

Cites:

Cited by: 1

Related to: 10